Fuji Pharma Co., Ltd. (TYO:4554)
1,361.00
+4.00 (0.29%)
May 2, 2025, 3:30 PM JST
Fuji Pharma Ratios and Metrics
Market cap in millions JPY. Fiscal year is October - September.
Millions JPY. Fiscal year is Oct - Sep.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | May '25 May 1, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
Market Capitalization | 33,246 | 30,950 | 28,337 | 25,121 | 28,416 | 38,917 | Upgrade
|
Market Cap Growth | -8.02% | 9.22% | 12.80% | -11.60% | -26.98% | -5.14% | Upgrade
|
Enterprise Value | 59,965 | 57,137 | 54,046 | 45,919 | 37,050 | 39,914 | Upgrade
|
Last Close Price | 1361.00 | 1255.03 | 1116.03 | 958.54 | 1047.76 | 1092.89 | Upgrade
|
PE Ratio | 7.52 | 5.04 | 8.25 | 9.32 | 11.68 | 18.67 | Upgrade
|
Forward PE | 9.36 | 7.24 | 8.29 | 8.47 | 12.03 | 20.48 | Upgrade
|
PS Ratio | 0.69 | 0.67 | 0.69 | 0.71 | 0.84 | 1.15 | Upgrade
|
PB Ratio | 0.70 | 0.68 | 0.69 | 0.70 | 0.87 | 0.97 | Upgrade
|
P/TBV Ratio | 0.94 | 0.94 | 0.92 | 0.99 | 0.94 | 1.05 | Upgrade
|
P/FCF Ratio | - | 22.54 | - | - | 12.89 | 11.29 | Upgrade
|
P/OCF Ratio | - | 7.46 | 14.78 | - | 4.74 | 6.75 | Upgrade
|
PEG Ratio | - | 1.12 | 1.12 | 1.12 | 1.12 | 1.12 | Upgrade
|
EV/Sales Ratio | 1.24 | 1.24 | 1.32 | 1.30 | 1.09 | 1.18 | Upgrade
|
EV/EBITDA Ratio | 6.58 | 7.56 | 7.85 | 7.04 | 6.79 | 7.68 | Upgrade
|
EV/EBIT Ratio | 11.37 | 14.72 | 14.01 | 12.15 | 11.06 | 12.71 | Upgrade
|
EV/FCF Ratio | - | 41.61 | - | - | 16.81 | 11.58 | Upgrade
|
Debt / Equity Ratio | 0.64 | 0.64 | 0.70 | 0.69 | 0.57 | 0.31 | Upgrade
|
Debt / EBITDA Ratio | 3.34 | 3.87 | 4.21 | 3.77 | 3.42 | 2.35 | Upgrade
|
Debt / FCF Ratio | - | 21.31 | - | - | 8.47 | 3.54 | Upgrade
|
Asset Turnover | 0.54 | 0.53 | 0.51 | 0.51 | 0.54 | 0.55 | Upgrade
|
Inventory Turnover | 1.39 | 1.51 | 1.39 | 1.50 | 1.70 | 1.77 | Upgrade
|
Quick Ratio | 0.62 | 0.66 | 0.63 | 0.68 | 1.10 | 2.16 | Upgrade
|
Current Ratio | 1.19 | 1.19 | 1.31 | 1.45 | 1.73 | 3.18 | Upgrade
|
Return on Equity (ROE) | 9.80% | 14.17% | 8.92% | 7.87% | 6.70% | 5.26% | Upgrade
|
Return on Assets (ROA) | 3.69% | 2.77% | 3.00% | 3.38% | 3.32% | 3.20% | Upgrade
|
Return on Capital (ROIC) | 4.47% | 3.35% | 3.70% | 4.23% | 4.04% | 3.83% | Upgrade
|
Return on Capital Employed (ROCE) | 9.40% | 7.20% | 6.90% | 7.30% | 7.60% | 6.20% | Upgrade
|
Earnings Yield | 13.23% | 19.86% | 12.12% | 10.73% | 8.56% | 5.36% | Upgrade
|
FCF Yield | - | 4.44% | -4.98% | -22.91% | 7.76% | 8.86% | Upgrade
|
Dividend Yield | 3.34% | 3.39% | 3.31% | 3.65% | 2.77% | 2.65% | Upgrade
|
Payout Ratio | - | 15.82% | 26.17% | 27.04% | 33.18% | 43.36% | Upgrade
|
Buyback Yield / Dilution | -0.05% | -0.04% | -0.03% | 9.58% | 13.77% | -2.06% | Upgrade
|
Total Shareholder Return | 3.30% | 3.35% | 3.28% | 13.23% | 16.54% | 0.59% | Upgrade
|
Updated Feb 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.